Upperton Pharma Solutions
Rebecca Gray is a seasoned professional in the pharmaceutical industry, currently serving as QC Manager at Upperton Pharma Solutions since August 2018, where responsibilities include managing the QC laboratory and supporting GMP manufacturing introduction. Prior experience includes roles as an Analytical Scientist at Quotient Sciences, focusing on drug formulation development, and as an Analytical Chemist at Aesica Formulation Development, ensuring pharmaceutical product analysis for GMP manufacturing. Earlier positions include Analytical Technician at Intertek, performing laboratory analysis for engineering facilities, and Assistant Scientist at the Environment Agency, preparing environmental samples for analysis. Rebecca Gray holds an MChem degree in Chemistry from The University of Sheffield, completed in 2011.
Upperton Pharma Solutions
Upperton Pharma Solutions is a specialist CDMO (contract development and manufacturing organisation) providing formulation and dosage form development services to the biotechnology and pharmaceutical industries. We offer our clients a complete development service, from early feasibility studies to process optimisation, scale up and clinical trial (GMP / IMP) manufacturing. We are able to enhance the performance and delivery of our client’s products by utilising an extensive range of formulation technologies. In particular we have world leading expertise and know-how in pharmaceutical spray dryings, probably the most versatile and fastest growing technology in the industry. We have experience of working with a range of dosage forms and the expertise to develop the most challenging of molecules. Our formulation work is supported by a comprehensive range of analytical services for product testing and ICH stability studies. Upperton has an extensive, multinational client-base, ranging from virtual and small start-ups to global pharma companies. We pride ourselves on our client-focused, flexible approach and scientific excellence.